I still didn't put it together, so I kept
A., Betzel, C., Meents, A., Chapman, H
More recently the potent GLP-1 RA, semaglutide, and the dual GLP-1/GIP receptor agonist, Tirzepatide has also been approved for weight loss indications
If approved, pills could lift capacity constraints and broaden adoption far beyond what cold-chain injectables alone can reach
In todays episode, were joined by scholar, national speaker, professor, and author of the Pulitzer prize winning book Franchise: The Golden Arches in Black America, Dr
Robert Popovian 00:29 And joining me is my good friend, Conner Mertens, from Seattle, Washington, my co-host and our numero uno, community outreach manager and patient advocate extraordinaire